Andrew Dudum $HIMS SEC Form 4 Insider Trading

Andrew Dudum has filed a total of 72 insider trades in $HIMS since 2021. Their most recent trade was a sale of 10,539 shares, made on Dec 17, 2024. Their largest trade was a sale of 577,007 shares, made on Feb 29, 2024. We estimate that they now own 681,756 shares of $HIMS, worth an estimated $20.7 million.

Insider Trading at $HIMS

There have been a total of 367 insider trades reported at $HIMS since 2021, with 330,100 shares purchased and 13.6 million shares sold. The most active insider traders in $HIMS stock have been Melissa Baird, Andrew Dudum, and Oluyemi Okupe. The most recent trade was a sale of 7,500 shares reported by Michael Chi (Chief Commercial Officer), made on Dec 19, 2024.

$HIMS Executives and Stock Owners with Insider Trades

• Melissa Baird, Chief Operating Officer

• Andrew Dudum, Chief Executive Officer

• Oluyemi Okupe, Chief Financial Officer

• Soleil Boughton, Chief Legal Officer

• Irene Becklund, PAO

• Michael Chi, Chief Commercial Officer

• Patrick Harrison Carroll, Chief Medical Officer

• Spencer Lee, Chief Financial Officer

• Michael Chi, Chief Marketing Officer

*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.